AIPL Antibodies

Santa Cruz Biotechnology features a diverse variety of AIPL Antibodies for advanced research in molecular biology. AIPL Antibodies targeting AIPL are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AIPL, or Aryl Hydrocarbon Receptor Interacting Protein-Like, plays a crucial role in cellular processes such as phototransduction and retinal health. Its function is vital for the maintenance of photoreceptor cells, and dysregulation of AIPL can lead to retinal degenerative diseases. Understanding AIPL's molecular mechanisms is essential for developing therapeutic strategies for vision-related disorders. Research focusing on AIPL expression patterns helps illuminate its role in retinal development and disease progression. Investigating AIPL interactions with other proteins provides insights into cellular signaling pathways and potential therapeutic targets. AIPL monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance our understanding of vision disorders and contribute to the development of new treatments.